000			01657 a2200445 4500
005			20250517200349.0
264		0	_c20180322
008			201803s 0 0 eng d
022			_a1768-3254
024	7		_a10.1016/j.ejmech.2018.01.021 _2doi
040			_aNLM _beng _cNLM
100	1		_aAboeldahab, Alshimaa M A
245	0	0	_aSpirohydantoins and 1,2,4-triazole-3-carboxamide derivatives as inhibitors of histone deacetylase: Design, synthesis, and biological evaluation. _h[electronic resource]
260			_bEuropean journal of medicinal chemistry _cFeb 2018
300			_a79-92 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntineoplastic Agents _xchemical synthesis
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCrystallography, X-Ray
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Design
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aHep G2 Cells
650	0	4	_aHistone Deacetylase Inhibitors _xchemical synthesis
650	0	4	_aHistone Deacetylases _xmetabolism
650	0	4	_aHumans
650	0	4	_aMCF-7 Cells
650	0	4	_aModels, Molecular
650	0	4	_aMolecular Structure
650	0	4	_aPolymerization _xdrug effects
650	0	4	_aStructure-Activity Relationship
650	0	4	_aTriazoles _xchemical synthesis
650	0	4	_aTubulin _xmetabolism
700	1		_aBeshr, Eman A M
700	1		_aShoman, Mai E
700	1		_aRabea, Safwat M
700	1		_aAly, Omar M
773	0		_tEuropean journal of medicinal chemistry _gvol. 146 _gp. 79-92
856	4	0	_uhttps://doi.org/10.1016/j.ejmech.2018.01.021 _zAvailable from publisher's website
999			_c28039968 _d28039968